IL-33 and ILC2 in pancreatic cancer: good, bad or a bit of both?
Saved in:
| Title: | IL-33 and ILC2 in pancreatic cancer: good, bad or a bit of both? |
|---|---|
| Authors: | Simpson C; University of Cambridge, CRUK Cambridge Institute, Cambridge, CB2 0RE, UK., Yip T; University of Cambridge, CRUK Cambridge Institute, Cambridge, CB2 0RE, UK., Halim TYF; University of Cambridge, CRUK Cambridge Institute, Cambridge, CB2 0RE, UK. Electronic address: Tim.Halim@cruk.cam.ac.uk. |
| Source: | Trends in cancer [Trends Cancer] 2025 Apr; Vol. 11 (4), pp. 274-275. Date of Electronic Publication: 2025 Mar 17. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Cell Press Country of Publication: United States NLM ID: 101665956 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2405-8025 (Electronic) Linking ISSN: 24058025 NLM ISO Abbreviation: Trends Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40102086 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: IL-33 and ILC2 in pancreatic cancer: good, bad or a bit of both? – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Simpson+C%22">Simpson C</searchLink>; University of Cambridge, CRUK Cambridge Institute, Cambridge, CB2 0RE, UK.<br /><searchLink fieldCode="AU" term="%22Yip+T%22">Yip T</searchLink>; University of Cambridge, CRUK Cambridge Institute, Cambridge, CB2 0RE, UK.<br /><searchLink fieldCode="AU" term="%22Halim+TYF%22">Halim TYF</searchLink>; University of Cambridge, CRUK Cambridge Institute, Cambridge, CB2 0RE, UK. Electronic address: Tim.Halim@cruk.cam.ac.uk. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101665956%22">Trends in cancer</searchLink> [Trends Cancer] 2025 Apr; Vol. 11 (4), pp. 274-275. <i>Date of Electronic Publication: </i>2025 Mar 17. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Cell+Press%22">Cell Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101665956 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2405-8025 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224058025%22">24058025 </searchLink><i>NLM ISO Abbreviation: </i>Trends Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40102086 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.trecan.2025.03.003 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 274 Titles: – TitleFull: IL-33 and ILC2 in pancreatic cancer: good, bad or a bit of both? Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Simpson C – PersonEntity: Name: NameFull: Yip T – PersonEntity: Name: NameFull: Halim TYF IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2025 Apr Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2405-8025 Numbering: – Type: volume Value: 11 – Type: issue Value: 4 Titles: – TitleFull: Trends in cancer Type: main |
| ResultId | 1 |